Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Newsletter subscription
Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Languages
ENGLISH
English (US)
ASIAN
Монгол
日本語
Tiếng Việt
Bahasa Indonesia
中文 (简体, 中国大陆)
EUROPEAN
Русский
Español (España)
Français (France)
MIDDLE_EAST_AFRICA
العربية
Search results for "IQ"
Home
"Does a Son Take After His Mother, and a Daughter After Her Father?"...Half True and Half False, What’s the Truth?
"A son takes after his mother," and "a daughter is just like her father" are sayings that feel familiar, almost like proverbs.
01/29/2026, 20:49 ET
Lexraza Developer and Lilly Obesity Chief to Headline Global Clinical Trial Summit in Seoul
What will it take to build on the success of Lexraza, South Korea’s landmark lung cancer drug, and propel it into the next generation of...
10/16/2026, 22:38 ET
FDA Approves Celltrion’s Avtozma for Pediatric COVID-19 in High-Risk Patients
Celltrion announced on October 7 that the U.S. Food and Drug Administration has approved an expanded pediatric...
10/08/2026, 05:21 ET
Beyond Cosmetics: Foreign Tourists Stock Up on Korean OTC Skin Ointments
Search TikTok for "must-buy items at Korean pharmacies," and a steady stream of video recommendations fills the screen.
09/21/2026, 22:29 ET
Celltrion Secures Dominant Market Share in Asia Led by Autoimmune and Oncology Biosimilars
Celltrion is consolidating its leading market position across major Asian countries with its key autoimmune and...
08/20/2026, 01:54 ET
Daewoong Pharmaceutical Secures 145.2 Billion Won MENA Export Deal for Diabetes Drug Enblo
Daewoong Pharmaceutical’s proprietary type 2 diabetes treatment, Enblo (active ingredient: enavogliflozin), is set to...
07/06/2026, 03:44 ET
Celltrion Secures Historic FDA Interchangeability Status for Truxima
Celltrion announced on the 1st that the U.S. Food and Drug Administration has granted interchangeable status to Truxima...
07/06/2026, 03:44 ET
A Milestone for K-Bio: Celltrion’s Truxima Surpasses Global Blockbuster Rituxan in U.S. Prescriptions
Truxima , a blood cancer treatment developed by Celltrion, has become the first Korean-made biosimilar to rank number...
04/09/2026, 01:13 ET
Forget the ‘Genius Brain’: Research Reveals the Real Traits of a Stock Expert
When the topic of stock investment arises, it is common to hear that some people simply have a "knack" for it or that...
03/13/2026, 06:16 ET
"The First Generation to Fall Behind?" Why Gen Z’s Cognitive Indicators are Wavering
Generation Z is the first generation to grow up with smartphones as a constant companion.
02/19/2026, 04:44 ET
1